financetom
Business
financetom
/
Business
/
BMO on The Day Ahead in Canada
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BMO on The Day Ahead in Canada
Mar 5, 2025 5:33 AM

08:05 AM EST, 03/05/2025 (MT Newswires) -- United States President Donald Trump defended his trade tariffs against Canada, Mexico and China in his Congress speech late Tuesday, saying it would raise "trillions and trillions" in revenue, said Bank of Montreal (BMO).

Trump acknowledged that any resulting economic pain could be just a "little disturbance" that the country can overcome, noted the bank. The president also highlighted the recent bond market rally. Ten-year U.S. Treasury yields are little changed early Wednesday at 4.22%, while the US dollar slipped.

Canada will release Q4 labor productivity at 8:30 a.m. ET Wednesday, pointed out BMO.

After some upward revisions to labor productivity last quarter, Canada could be in for some more good news in Q4. The bank estimates productivity rose 0.8%, as gross domestic product growth accelerated while hours worked were constrained by labor stoppages.

This would be just the third quarter of rising productivity since the pandemic distortions in 2020. Still, the big picture remains one of weakness, especially in contrast with the U.S, added BMO. While that provides an opportunity for Canadian businesses to make productivity-enhancing investments, it can also act as an obstacle to attracting business investment from outside Canada --which is already struggling in the uncertain trade environment.

Toronto home sales figures were released early Wednesday, with activity remaining lacklustre in February amid affordability challenges and weak household confidence, according to the bank.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US to allow transactions involving Lukoil and Caspian Pipeline Consortium, website shows
US to allow transactions involving Lukoil and Caspian Pipeline Consortium, website shows
Nov 14, 2025
WASHINGTON (Reuters) -The United States issued general licenses on Friday authorizing transactions involving certain Lukoil entities in Bulgaria and petroleum services and other transactions related to the Caspian Pipeline Consortium, a posting on the Treasury Department's website showed. Another license also authorized companies to talk to Lukoil about buying their foreign assets. ...
Phaos Technology Announces Closing of Initial Public Offering
Phaos Technology Announces Closing of Initial Public Offering
Nov 14, 2025
SINGAPORE, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, , (“Phaos” or “the Company”), the investment holding company of Phaos Technology Pte. Ltd., an advanced microscopy solutions Company, today announced the closing of its previously announced initial public offering of an aggregate of 2,700,000 class A ordinary shares of the Company (the “Offering”) at a public offering price...
Disney Expected to Report Double-Digit EPS Growth for Next Two Years, UBS Says
Disney Expected to Report Double-Digit EPS Growth for Next Two Years, UBS Says
Nov 14, 2025
02:43 PM EST, 11/14/2025 (MT Newswires) -- Walt Disney ( DIS ) is expected to report double-digit earnings per share growth for the next two years, with cash generation continuing to improve and about $10 billion of free cash flow expected in fiscal 2026, UBS said. The brokerage said in a Thursday note that it expected fiscal 2026 revenue of...
Sarepta Therapeutics' Elevidys Receives Boxed Warning, Narrowed Indication After Fatal Liver Injury Reports, FDA Says
Sarepta Therapeutics' Elevidys Receives Boxed Warning, Narrowed Indication After Fatal Liver Injury Reports, FDA Says
Nov 14, 2025
02:43 PM EST, 11/14/2025 (MT Newswires) -- Sarepta Therapeutics' ( SRPT ) Elevidys gene therapy will now carry a boxed warning and a restricted indication following reports of fatal acute liver failure in non-ambulatory Duchenne muscular dystrophy patients, the US Food and Drug Administration said Friday. The FDA revised the label to limit Elevidys to ambulatory patients aged four and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved